Suparna R Krishnaiengar

Suparna R Krishnaiengar, M.D.

Assistant Professor; Associate Program Director, Neurology Residency

Department: Neurology – Jacksonville

About Suparna R Krishnaiengar

Suparna Krishnaiengar, M.D., is a University of Florida assistant professor of neurology and a neurologist at the UF Health Neuroscience Institute in Jacksonville specializing in clinical neurophysiology and epilepsy. She also serves as associate program director for the Neurology Residency Program.

Dr. Krishnaiengar received her medical degree from the University of Mysore in Mysore, India. She completed residency training in neurology, as well as a fellowship in clinical neurophysiology, at Oklahoma University Health Sciences Center in Oklahoma City, Oklahoma. She also completed a fellowship in clinical neurophysiology, electroencephalography and epilepsy at the Cleveland Clinic Foundation in Cleveland, Ohio. Dr. Krishnaiengar is board-certified in neurology, clinical neurophysiology and epilepsy.

Additional Positions:
Associate Program Director
2017 – Current · Neurology Residency
Assistant Professor of Neurology
2011 – Current · University of Florida

Accomplishments

Exemplary Teacher Award
2020 · University of Florida College of Medicine – Jacksonville

Teaching Profile

Courses Taught
2021
MDC7800 Neurology Clerkship

Board Certifications

  • Clinical Neurophysiology
    American Board of Psychiatry and Neurology
  • Epilepsy
    American Board of Psychiatry and Neurology
  • Neurology
    American Board of Psychiatry and Neurology

Clinical Profile

Specialties
  • Neurology
Subspecialties
  • Clinical Neurophysiology
  • Epilepsy

Publications

2023
Long-term quality of life in patients with focal seizures treated with adjunctive eslicarbazepine acetate.
Epilepsy & behavior : E&B. 148 [DOI] 10.1016/j.yebeh.2023.109466. [PMID] 37839247.
2023
Time to baseline seizure count in patients with focal seizures receiving adjunctive eslicarbazepine acetate in a phase IV clinical trial.
Clinical neurology and neurosurgery. 225 [DOI] 10.1016/j.clineuro.2022.107552. [PMID] 36657359.
2021
Prolonged post-ictal atrial fibrillation following seizures.
Epilepsy & behavior reports. 16 [DOI] 10.1016/j.ebr.2021.100481. [PMID] 34693244.
2019
Adult Presentation of Ornithine Transcarbamylase Deficiency: 2 Illustrative Cases of Phenotypic Variability and Literature Review.
The Neurohospitalist. 9(1):30-36 [DOI] 10.1177/1941874418764817. [PMID] 30671162.
2011
Seizure semiology and aging.
Epilepsy & behavior : E&B. 20(2):375-7 [DOI] 10.1016/j.yebeh.2010.12.033. [PMID] 21273137.

Grants

Apr 2022 ACTIVE
AN OPEN-LABEL, MULTICENTER, OUTPATIENT EXTENSION STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF STACCATO ALPRAZOLAM IN STUDY PARTICIPANTS 12 YEARS OF AGE AND OLDER WITH STEREOTYPICAL PROLONGED SEIZURES
Role: Principal Investigator
Funding: PAREXEL INTERNATIONAL CORP via UCB BIOPHARMA SRL
Apr 2022 ACTIVE
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, OUTPATIENT, PARALLEL-GROUP STUDY TO ASSESS THE EFFICACY AND SAFETY OF STACCATO ALPRAZOLAM IN STUDY PARTICIPANTS 12 YEARS OF AGE AND OLDER WITH STEREOTYPICAL PROLONGED SEIZURES
Role: Principal Investigator
Funding: PAREXEL INTERNATIONAL CORP via UCB BIOPHARMA SRL
May 2020 – Feb 2023
AN OPEN-LABEL, MULTICENTER, EXTENSION STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PADSEVONIL AS ADJUNCTIVE TREATMENT OF FOCAL ONSET SEIZURES IN ADULT SUBJECTS WITH DRUG-RESISTANT EPILEPSY
Role: Principal Investigator
Funding: PAREXEL INTERNATIONAL CORP via UCB BIOSCIENCES
Mar 2020 – Nov 2023
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 as Adjunctive Therapy in Focal-onset Epilepsy
Role: Principal Investigator
Funding: NCGS via XENON PHARMACEUTICALS
Apr 2019 – Feb 2023
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-Onset Seizures in Adult Subjects with Drug-Resistant Epilepsy
Role: Principal Investigator
Funding: PAREXEL INTERNATIONAL CORP via UCB BIOSCIENCES

Education

Epilepsy Fellowship
2009 · Cleveland Clinic Foundation
Clinical Neurophysiology Fellowship
2008 · Oklahoma University Health Sciences Center
Neurology Residency
2007 · Oklahoma University Health Sciences Center
Bachelor of Medicine, Bachelor of Surgery
1994 · University of Mysore

Contact Details

Addresses:
Business Mailing:
653 W 8TH ST
JACKSONVILLE FL 32209